Treating PNH: Understanding Complement Inhibitors, Modes of Administration, and Coordinated Patient Care Needs

Dr. Haumschild drives a discussion providing an overview of PNH and pathology of the disease.

Medical experts illustrate the nature of hemolysis in PNH and characteristics unique to the disease state.

Key opinion leaders navigate barriers to optimal care for patients receiving treatment for PNH.

Dr Haumschild drives a discussion surrounding impactful PNH treatment strategies.

Dr Haumschild continues leading a discussion surrounding management of PNH, emphasizing the impact of complement inhibitors.

Medical experts highlight unmet needs in the PNH treatment landscape and considerations for utilizing eculizumab.

Dr Haumschild continues leading an expert discussion surrounding key strategies and pain points in PNH treatment.

Expert panelists evaluate results regarding complement inhibitor trials for utilization in PNH management.

Economic impacts on patients receiving treatment for PNH and a conversation surrounding treatment adherence are discussed by key opinion leaders.

Dr Haumschild continues leading a discussion surrounding potential treatment advancements in the PNH landscape.

Dr Haumschild and a panel of medical experts underscore financial considerations in PNH treatment.

Key considerations for transfusion requirements in patients with PNH are discussed by key opinion leaders.

Medical experts navigate significant challenges associated with PNH treatment.

Key discussion points for educating patients on infection risk management in PNH care are highlighted.

Barriers to care and treatment adherence for patients diagnosed with PNH is discussed.

The panelists provide their final thoughts, highlighting financial considerations in PNH treatment.